HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, S. C. Articles by Gardner, J. D. Search for Related Content PubMed PubMed Citation Articles by Huang, S. C. Articles by Gardner, J. D. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 42, 26121-26126, Oct, 1994

Multiple affinity states of different cholecystokinin receptors

SC Huang, KP Fortune, SA Wank, AS Kopin and JD Gardner
Department of Internal Medicine, St. Louis University Health Sciences Center, Missouri 63104.

We transfected COS cells with cDNA for rat cholecystokinin-A (CCK-A) and different CCK-B receptors and measured binding of 125I-CCK-8, [3H]L- 364,718 and [3H]L-365,260 to characterize the different affinity states for each type of CCK receptor. Rat CCK-A and CCK-B receptors, canine CCK-B receptors and canine mutant CCK-B (M-CCK-B) receptors in which the leucine in position 355 was replaced by valine each existed in three different affinity states for CCK-8, high affinity, low affinity, and very low affinity. In rat CCK-A and probably CCK-B receptors, most were in the very low affinity state, whereas with canine CCK-B and M- CCK-B receptors, most were in the low affinity state. Studies with CCK receptor agonists, CCK-8, gastrin, and CCK-JMV-180, in conjunction with CCK receptor antagonists, L-364,718 and L-365,260, showed a different pattern of affinities for these ligands at the different CCK receptors. Thus, each transfected CCK receptor can exist in three different affinity states for CCK-8 and has a characteristic pattern of interaction with different ligands. This ability to exist in multiple affinity states is an intrinsic property of the CCK receptor molecule itself.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]

				A. Pace, L. J. Garcia-Marin, J. A. Tapia, M. J. Bragado, and R. T. Jensen Phosphospecific Site Tyrosine Phosphorylation of p125FAK and Proline-rich Kinase 2 Is Differentially Regulated by Cholecystokinin Receptor Type A Activation in Pancreatic Acini J. Biol. Chem., May 23, 2003; 278(21): 19008 - 19016. [Abstract] [Full Text] [PDF]

				X.-Q. Ding, D. I. Pinon, K. E. Furse, T. P. Lybrand, and L. J. Miller Refinement of the Conformation of a Critical Region of Charge-Charge Interaction between Cholecystokinin and Its Receptor Mol. Pharmacol., May 1, 2002; 61(5): 1041 - 1052. [Abstract] [Full Text] [PDF]

				C. Escrieut, V. Gigoux, E. Archer, S. Verrier, B. Maigret, R. Behrendt, L. Moroder, E. Bignon, S. Silvente-Poirot, L. Pradayrol, et al. The Biologically Crucial C Terminus of Cholecystokinin and the Non-peptide Agonist SR-146,131 Share a Common Binding Site in the Human CCK1 Receptor. EVIDENCE FOR A CRUCIAL ROLE OF MET-121 IN THE ACTIVATION PROCESS J. Biol. Chem., February 22, 2002; 277(9): 7546 - 7555. [Abstract] [Full Text] [PDF]

				F. Noble, S. A. Wank, J. N. Crawley, J. Bradwejn, K. B. Seroogy, M. Hamon, and B. P. Roques International Union of Pharmacology. XXI. Structure, Distribution, and Functions of Cholecystokinin Receptors Pharmacol. Rev., December 1, 1999; 51(4): 745 - 781. [Abstract] [Full Text] [PDF]

				Z.-L. Xiao, Q. Chen, J. Amaral, P. Biancani, R. T. Jensen, and J. Behar CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1401 - G1407. [Abstract] [Full Text] [PDF]

				S. Silvente-Poirot, C. Escrieut, and S. A. Wank Role of the Extracellular Domains of the Cholecystokinin Receptor in Agonist Binding Mol. Pharmacol., August 1, 1998; 54(2): 364 - 371. [Abstract] [Full Text]

				V. Gigoux, C. Escrieut, S. Silvente-Poirot, B. Maigret, L. Gouilleux, J.-A. Fehrentz, D. Gully, L. Moroder, N. Vaysse, and D. Fourmy Met-195 of the Cholecystokinin-A Receptor Interacts with the Sulfated Tyrosine of Cholecystokinin and Is Crucial for Receptor Transition to High Affinity State J. Biol. Chem., June 5, 1998; 273(23): 14380 - 14386. [Abstract] [Full Text] [PDF]

				B. Ji, A. S. Kopin, and C. D. Logsdon Species Differences between Rat and Mouse CCKA Receptors Determine the Divergent Acinar Cell Response to the Cholecystokinin Analog JMV-180 J. Biol. Chem., June 16, 2000; 275(25): 19115 - 19120. [Abstract] [Full Text] [PDF]